1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Nanalysis Scientific Corp.

Nanalysis Scientific Corp.

NSCIF
Nanalysis Scientific Corp.US flagOther OTC
0.10
USD
+0.01
- -
13.93MMarket Cap

Total Valuation

Nanalysis Scientific Corp. carries a market capitalization of 13.93M, placing it among publicly traded companies globally. Its enterprise value stands at 30.46M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap13.93M
Enterprise Value30.46M

Share Statistics

Nanalysis Scientific Corp. currently has 139.34M shares outstanding.

Shares Outstanding139.34M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.39, and the price-to-book ratio stands at 1.38.

PE RatioN/A
PS Ratio0.39
PB Ratio1.38
P/TBV Ratio-3.75
P/FCF Ratio3.97
P/OCF Ratio5.43

Enterprise Valuation

On an enterprise value basis, Nanalysis Scientific Corp. trades at an EV/EBITDA multiple of 25.32 and an EV/FCF ratio of 6.03.

EV / Sales0.75
EV / EBITDA25.32
EV / EBITN/A
EV / FCF6.03

Financial Position

Nanalysis Scientific Corp. maintains a current ratio of 1.03, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 113.14, indicating elevated leverage, while an interest coverage ratio of 1.16 demonstrates limited ability to service its debt obligations.

Current Ratio1.03
Quick Ratio0.65
Debt / Equity113.14
Debt / EBITDA11.60
Interest Coverage1.16

Financial Efficiency

Return on Equity (ROE)-33.43
Return on Assets (ROA)-11.73
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover7.03

Taxes

Income Tax16,000.00
Effective Tax RateN/A

Stock Price Statistics

Nanalysis Scientific Corp.'s stock has declined approximately -27.10145% over the past 52 weeks. The 50-day moving average sits at 0.09, while the 200-day moving average is 0.10.

Beta (5Y)N/A
52-Week Price Change-27.10145%
50-Day Moving Average0.09
200-Day Moving Average0.10
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Nanalysis Scientific Corp. generated 40.35M in revenue and converted that into -4.18M in net income, yielding earnings per share of -0.03. EBITDA reached 1.20M, while operating income came in at -2.03M.

Revenue40.35M
Gross Profit9.86M
Operating Income-2.03M
Pretax Income-4.16M
Net Income-4.18M
EBITDA1.20M
EBIT-2.03M
Earnings Per Share (EPS)-0.03

Balance Sheet

Nanalysis Scientific Corp. holds 540,000.00 in cash and equivalents against 13.96M in total debt, resulting in a net debt position of 12.24M. Total book value stands at 12.34M, with working capital of 447,000.00 providing operational flexibility.

Cash & Cash Equivalents540,000.00
Total Debt13.96M
Net Debt12.24M
Equity (Book Value)12.34M
Book Value Per Share0.09
Working Capital447,000.00

Cash Flow

Nanalysis Scientific Corp. produced 2.93M in operating cash flow over the past twelve months. After subtracting -1.08M in capital expenditures, free cash flow totaled 1.85M - equivalent to 0.01 per share.

Operating Cash Flow2.93M
Capital Expenditures-1.08M
Free Cash Flow1.85M
FCF Per Share0.01

Margins

Nanalysis Scientific Corp. operates with a gross margin of 24.44, reflecting its pricing power and cost economics. The operating margin of -5.02 and net profit margin of -10.35 provide insight into operational efficiency.

Gross Margin24.44
Operating Margin-5.02
Pretax Margin-10.31
Profit Margin-10.35
EBITDA Margin2.98

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield10.53
FCF Yield25.22

Scores

Nanalysis Scientific Corp. posts an Altman Z-Score of -2.18, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-2.18